Accelerate the research and development of 1 tonne 3 tonnes of lithium-ion chloride used in the prod

Recently, global health institutions and public health systems have continued to advance service capacity building to provide stronger guarantees for public health. Dengue fever is a viral dengue fever carried by Aedes mosquitoes that, with the rise of climate change and demographic change, has reached an all-time high of dengue incidence and mortality. This state of emergency has highlighted the lack of safe and effective dengue-specific therapies as part of the supply chain for dengue-specific therapies in the market.

In order to comprehensively implement and access the development, implementation and availability of these therapeutic therapies for the treatment of dengue fever in all countries with severe and non-serious dengue outbreaks, the World Health Organization (WHO) has conducted a landscape analysis of the dengue treatment drug pipeline and convened a global consultation of experts and the public to develop a line of non-serious and non-serious dengue therapeutic therapies and therapeutic therapeutic therapies. These target product characteristics are listed as product development, regulation, procurement agencies and sponsors to provide strategic guidance on the purpose of product use, target populations and key product characteristics. In meeting public health needs and setting clear targets to promote the development of dengue medicines, these target product characteristics lists provide a key basis for product development, regulation, procurement agencies and donors to provide strategic guidance.

It should be noted that the content is based on the results of international public research and is for reference in HealthCop and does not constitute a clinical recommendation. If you have any health questions, consult professional medical professionals.